IP Library Granted Patent US 6,893,640
Granted Patent B2
US 6,893,640 · App. 10/314,639 · Granted May 17, 2005

Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis

Assignee: The Ohio State University Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,893,640
App. No.
10/314,639
Granted
May 17, 2005
Kind
B2
Abstract

Diagnostic tools for for serodiagnosing ehrlichiosis in mammals, particularly in members of the Canidae family and in humans are provided. The diagnostic tools are a group of outer membrane proteins of E. chaffeensis and variants thereof, referred to hereinafter as the “OMP proteins”, a group of outer membrane proteins of E. canis and variants thereof referred to hereinafter as the “P30F proteins”, and antibodies to the OMP proteins and the P30F proteins. The OMP proteins of E. chaffeensis encompass OMP-1, OMP-1A, OMP1-B, OMP-1C, OMP1-D, OMP1-E, OMP1-F, OMP1-H, OMP-1R, OMP-1S, OMP-1T, OMP-1U, OMP-1V, OMP-1W, OMP-1X, OMP-1Y and OMP-1Z. The P30F proteins of E. canis encompass P30, P30 a , P30-1, P30-2, P30-3, P30-4, P30-5, P30-6, P30-7, P30-8, P30-9, P30-10, P30-11, and P30-12. Isolated polynucleotides that encode the E. chaffeensis OMP proteins and isolated polynucleotides that encode the E. canis P30F protein are also provided. The present invention also relates to kits containing reagents for diagnosing human ehrlichiosis and canine ehrlichiosis, and to immunogenic compositions containing one or more OMP proteins or P30F proteins.

Claims (6)

1. A method for diagnosing an infection with E. canis in a Canidae patient comprising the steps of:

(a) providing a serum sample from the patient;

(b) providing an isolated or purified P30-10 protein of E. canis;

(c) contacting the serum sample with the P30-10 protein; and

(d) assaying for the formation of a complex between antibodies in the serum sample and the P30-10 protein, wherein formation of said complex is indicative of infection with E. canis.

2. The method of claim 1 wherein the E. canis P30-10 protein comprises amino acid 26 through amino acid 280 of the sequence set forth in SEQ ID NO. 48.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2018
From: RIKIHISA, YASUKO; OHASHI, NORIO
To: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 047215/0239 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2018
From: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 047215/0400 →
CONFIRMATORY LICENSE Recorded Jul 16, 2018
From: OHIO STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046546/0817 →
Continuity (3)
Division 0931470100 · May 19, 1999
Provisional Application 6010085300 · Sep 18, 1998
Related Publication 20030103991A1 · Jun 5, 2003